Only 6 papers report the use of tumor markers measurement (carcinoembryonic antigen and carbohydrate antigen 15–3) during follow-up [46,48,57,75,82,88] and none includes the use of computed tomography scans, positron emission tomography scanning and magnetic resonance imaging. This evidence concerns the gene CEACAM5 and neoplasm.